LS CancerDiag Rebrands to Lynsight

About Lynch Syndrome
For Patients & Families
For Providers
For Payers
Lynch Syndrome Testing
About
- Team & Culture
Lynch Syndrome Resources
Contact Us

Menu

About Lynch Syndrome
For Patients & Families
For Providers
For Payers
Lynch Syndrome Testing
About
- Team & Culture
Lynch Syndrome Resources
Contact Us

About Lynch Syndrome
For Patients & Families
For Providers
For Payers
Lynch Syndrome Testing
About

Menu

About Lynch Syndrome
For Patients & Families
For Providers
For Payers
Lynch Syndrome Testing
About

Mechanisms of pathogenicity in human MSH2 missense mutants

Written by altitudemarketing on October 2, 2008

Posted Under:

Search

Recent Posts

Meet our Team: Maria Jäntti
Lynsight Makes a Lasting Impression at CGA-IGC 2024
Meet our Team: Niklas Lahti
Lynch syndrome lingo: 13 terms you & your family should know
Managing Lynch Syndrome: 4 Strategies for Prevention, Early Detection & Support

Recent Comments

No comments to show.

Archives

January 2025
December 2024
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
March 2024
February 2024
December 2023
October 2023
July 2023
June 2023
May 2023
March 2023
June 2022

Categories

Frequently Asked Questions
News
Team
Uncategorized

Sign Up For the Latest From Lynsight

Email

About Lynch Syndrome

For Patients & Families

Lynch Syndrome Testing

Lynch Syndrome Resources

Certifications & Credentials

Patent Information

Test Instructions For Patients

FI25582879
Arabiankatu 12
00560 Helsinki
Finland

+358 40 660 2622

Website Designed & Developed by Altitude Marketing